Speech of Kids After Neonatal Encephalopathy
SANE
Investigating the Prognostic Accuracy of Different Biomarkers for Detection of Developmental Language Disorder in Children With Neonatal Encephalopathy
1 other identifier
observational
93
1 country
1
Brief Summary
The goal of this ambispective cohort study is to reveal the early indicators of delayed language development in children born with hypoxic-ischemic encephalopathy (HIE). We will examine the prognostic accuracy of different biomarkers, with a special focus on the ADC values of the corpus callosum. The main questions it aims to answer are:
- 1.To what extent does hypoxic-ischemic encephalopathy (HIE) in infancy affect intellectual development (IQ), receptive and expressive language abilities at different levels of the language system, and memory capacities related to language development?
- 2.What is the relationship between early biomarkers of brain injury-such as blood gas levels, lactate, aEEG, and MRI findings (Weeke scoring system, ADC values of the corpus callosum)-and long-term cognitive developmental outcomes?
- 3.What is the incidence of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in this high-risk population of infants with HIE?
- 4.Is there an association between the Weeke Total Score and long-term language developmental outcomes?
- 5.Can restricted diffusion (ADC values) of the splenium of the corpus callosum serve as an early neuroradiological marker of developmental language disorder (DLD)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 22, 2025
August 1, 2025
1.7 years
August 14, 2025
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive abilities - WPPSI-IV
At the age of 4-7 years
Language abilities - KOBAK
At the age of 4-7 years
Secondary Outcomes (6)
Socioeconomic status - Socioeconomic questionnaire
At the age of 4-7 years
Parental concerns - Jaworsky Questionnaire
At the age of 4-7 years
Social and Communication skills - Social Communication Questionnaire
At the age of 4-7 years
Digital screen use - ScreenQ
At the age of 4-7 years
ADHD traits - ADHD Rating Scale
At the age of 4-7 years
- +1 more secondary outcomes
Study Arms (1)
Children born with Hypoxic-Ischemic Encephalopathy (HIE)
Eligibility Criteria
Children with HIE
You may qualify if:
- Born at ≥ 35th week of gestation
- Attended follow-up examinations at two years of age
- Has parental informed consent
You may not qualify if:
- Hearing loss
- Multilingual language environment
- Congenital abnormalities
- Metabolic disease
- Sudden unexpected postnatal collapse
- Brain injury not caused by HIE
- Severe motor impairment defined as a score \<70 on the psychomotor development index (PDI) at 2 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Semmelweis Universitylead
- UiT The Arctic University of Norwaycollaborator
- Budapest University of Technology and Economicscollaborator
- Eotvos Lorand Universitycollaborator
Study Sites (1)
Semmelweis University
Budapest, Hungary
Related Publications (5)
Bartha-Doering L, Kollndorfer K, Schwartz E, Fischmeister FPS, Alexopoulos J, Langs G, Prayer D, Kasprian G, Seidl R. The role of the corpus callosum in language network connectivity in children. Dev Sci. 2021 Mar;24(2):e13031. doi: 10.1111/desc.13031. Epub 2020 Sep 1.
PMID: 32790079BACKGROUNDWeeke LC, Groenendaal F, Mudigonda K, Blennow M, Lequin MH, Meiners LC, van Haastert IC, Benders MJ, Hallberg B, de Vries LS. A Novel Magnetic Resonance Imaging Score Predicts Neurodevelopmental Outcome After Perinatal Asphyxia and Therapeutic Hypothermia. J Pediatr. 2018 Jan;192:33-40.e2. doi: 10.1016/j.jpeds.2017.09.043.
PMID: 29246356BACKGROUNDNi Bhroin M, Kelly L, Sweetman D, Aslam S, O'Dea MI, Hurley T, Slevin M, Murphy J, Byrne AT, Colleran G, Molloy EJ, Bokde ALW. Relationship Between MRI Scoring Systems and Neurodevelopmental Outcome at Two Years in Infants With Neonatal Encephalopathy. Pediatr Neurol. 2022 Jan;126:35-42. doi: 10.1016/j.pediatrneurol.2021.10.005. Epub 2021 Oct 13.
PMID: 34736061BACKGROUNDChin EM, Jayakumar S, Ramos E, Gerner G, Soares BP, Cristofalo E, Leppert M, Allen M, Parkinson C, Johnston M, Northington F, Burton VJ. Preschool Language Outcomes following Perinatal Hypoxic-Ischemic Encephalopathy in the Age of Therapeutic Hypothermia. Dev Neurosci. 2019 Jun 5:1-11. doi: 10.1159/000499562. Online ahead of print.
PMID: 31167188BACKGROUNDOuwehand S, Smidt LCA, Dudink J, Benders MJNL, de Vries LS, Groenendaal F, van der Aa NE. Predictors of Outcomes in Hypoxic-Ischemic Encephalopathy following Hypothermia: A Meta-Analysis. Neonatology. 2020;117(4):411-427. doi: 10.1159/000505519. Epub 2020 Apr 1.
PMID: 32235122BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 7 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2025
First Posted
August 22, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 22, 2025
Record last verified: 2025-08